Epidural analgesia is associated with a four-to five-fold increase in noninfectious maternal fever in nulliparous women. Fever prophylaxis may safely reduce both unnecessary neonatal sepsis evaluations and the potential effect of fever on the fetus.
INTRODUCTION
Nulliparas randomized to epidural analgesia consistently demonstrate a significantly elevated rate of intrapartum fever: 24-33% in the epidural analgesia arm compared to 5-7% among those receiving parenteral narcotics. 1, 2 Hyperthermia in response to epidural analgesia in labor is paradoxical, given the vasodilatation that accompanies epidural analgesia usually results in a decrease in core temperature. 3 Although acquired infection is a possibility, several observations render this less likely. First, neonatal sepsis evaluations are frequent after epidural analgesia, but increased neonatal infections have not been documented, despite incomplete antibiotic treatment rates. [5] [6] [7] Second, nulliparas with epidural labor longer and receive more vaginal exams, on average, but labor is prolonged by only 52 minutes. 1 Third, women with long labors in the absence of epidural analgesia have low rates of fever. 5 If the explanation is not infection, but perturbations of maternal thermoregulation, 4 fever prophylaxis has the potential to safely reduce the rate of neonatal sepsis evaluations and mitigate against deleterious effects of fever on the fetus. The objective of our current study was to examine whether acetaminophen, a centrally acting agent, would effectively prevent maternal hyperthermia when administered at the standard dose used to treat intrapartum fever at our institution.
MATERIALS AND METHODS
A randomized double-blind placebo-controlled trial was performed at Ben Taub General Hospital between April and August of 2001. Inclusion criteria were nulliparity, full-term pregnancy (>37 weeks), vertex presentation, ability to provide informed consent, and request for epidural analgesia to control labor pain. Women with a temperature >99.51F at any time prior to epidural placement, pre-eclampsia, liver disease, or acetaminophen allergy were excluded. All patients were fully counseled prior to epidural placement and signed an IRB-approved consent form. Consenting women were randomized at epidural placement to acetaminophen 650 mg, per rectum, or to placebo suppositories, every 4 hours. The dose and route of acetaminophen represents the standard at our institution for the treatment of intrapartum fever. The initial dose of acetaminophen was administered immediately after epidural placement when the patient returned to the left lateral position. Randomization was performed using a computer random number generator, with a blocking strategy to ensure approximate equal sample sizes in each group.
At our institution, epidural analgesia is usually made available to the laboring patient after cervical dilation of 3-4 cm is documented. Patients are loaded with one of three local anesthetic solutions to obtain a sensory level of T10 (0.25% bupivacaine, 0.125% bupivacaine or 0.0625% bupivacaine with 2.5 mg/cm 3 of fentanyl). Maintenance analgesia is provided at a concentration of 0.0625% bupivacaine with 2.5 mg/cm 3 of fentanyl at 8-14 cm 3 / hour to maintain the desired sensory level. Following epidural placement, maternal temperatures were obtained hourly until delivery using a tympanic membrane thermometer (Braun Thermoscan PRO 3000) to eliminate the effects of oral intake and mouth breathing. In our unit, labor room temperatures are determined by central control. No individual temperature controls are present in labor rooms. The mean labor room temperature is 71.8±0.851F .
The decision to initiate maternal antibiotic treatment for chorioamnionitis was based on the clinical judgment of the obstetrician. At our institution, the diagnosis of chorioamnionitis is generally made in the setting of maternal temperature >100.41F on two occasions. Fundal tenderness is not used in the setting of epidural analgesia. The study protocol required all infants to undergo a surveillance blood culture within 2 hours of birth. After birth, neonates were managed and evaluated based on clinical criteria. Neonatal sepsis evaluation is performed on asymptomatic neonates only in the setting of a maternal diagnosis of chorioamnionitis by the obstetrician. Neonatal sepsis evaluation consists of a neonatal blood culture and neonatal antibiotic treatment until the culture returns as negative. All neonates manifesting symptoms of possible sepsis receive evaluation regardless of the presence or absence of maternal fever and, in addition, undergo an examination and culture of their spinal fluid for evidence of meningitis.
Study placentas were sent for histologic examination performed by a pathologist (DC) blinded to both treatment group and the patient's clinical course in labor. Histologic grading of placental and umbilical cord inflammation was performed according to a standardized protocol. Placental inflammation was defined as the presence of inflammatory cells at the chorionic plate. Funisitis was defined as the invasion of the walls of the umbilical vessels with neutrophils.
Our primary study outcome was maternal temperature after epidural placement. Our sample size of 240 temperature measurements over time achieves 90% power to detect a significant effect of acetaminophen treatment at an alpha of 0.05, using the F-test in a multiple linear regression model. The power analysis took into account the fact that repeated temperature measurements are not independent. Univariate statistical analysis was performed utilizing Student's t-test, w 2 or Mann-Whitney U-tests as appropriate (SPSS 8.0, Chicago, IL). Multiple logistic regression analysis was performed using the Proc-GLM function (SAS 7.0, Cary, NC). A p-value of <0.05 was considered significant.
RESULTS
A total of 42 patients were enrolled. In all, 21 patients were randomized to the placebo group and 21 to the acetaminophen group. The characteristics of the women randomized to each study group are presented (Table 1 ). Our population is predominantly Hispanic. Women randomized to acetaminophen were, on average, 3.5 years older and 6 days further along in gestation age than women who received placebo. There were no significant differences between the two treatment groups in risk factors for underlying or acquired intrapartum infection. Initial maternal temperature and white blood cell count were not significantly different. In addition, rates of group B streptococcus (GBS) carriage were identical.
Treatment with acetaminophen had no effect on maternal temperature over the course of labor (Figure 1 ). Multiple linear regression analysis confirmed that acetaminophen did not significantly affect maternal temperature over time (p ¼ 0.65). Nor was there a significant interaction between acetaminophen treatment and time (p ¼ 0.99). Interestingly, only maternal age had a significant association with mean temperature; however, controlling for maternal age did not explain the absence of an effect of acetaminophen. Additional pregnancy outcomes are shown in Table 2 . The rate of fever was identical in the placebo and acetaminophen groups, occurring in 23.8% of the total study (p ¼ 1.0). Despite a trend towards increased birthweight in the acetaminophen group, no resultant increase in the length of labor was observed. A higher rate of intrauterine pressure catheter (IUPC) use was observed in the acetaminophen group that, although not statistically significant, may have been associated with an increased risk of infection in this group. Neonatal blood cultures were obtained within 2 hours of delivery in 93% of study neonates and all were negative. The three neonates with missing blood cultures were all born to afebrile mothers.
Placental specimens were available for examination in 33 of the 42 subjects. There was no difference in placental inflammation or funisitis between the acetaminophen and placebo groups. Placental inflammation was more common in the placentas of febrile women, although this result was not statistically significant (88.9 vs 66.7%, p ¼ 0.21). However, invasion of the umbilical vessels by inflammatory cells was significantly more common in the setting of fever (55.6 vs 16.7%, p ¼ 0.04).
COMMENT
Epidural analgesia provides the most effective form of pain relief for women in labor and is often considered a desirable option, especially by nulliparous women. However, in randomized trials, nulliparas experience a four-to five-fold increased rate of fever after epidural analgesia.
1,2 Despite the lack of infectious neonatal morbidity, 5, 6 there are several important reasons to prevent epidural fever. First, no well-validated strategies have been tested to distinguish epidural fever from infectious fever; thus, epidural fever results in an increased rate of neonatal sepsis workups, more frequent neonatal antibiotic treatment, and longer neonatal lengths of stay. 5 These neonatal interventions are potentially unnecessary, but neonatologists are reluctant to forgo them. The net effect is increased medical costs and maternal anxiety. Second, mounting evidence suggests that intrapartum fever per se (irrespective of etiology) may not be benign for the neonate, potentially lowering the fetal threshold for hypoxic brain injury. Intrapartum fever has been associated with a three-to four-fold increased rate of neonatal seizures in case control and prospective cohort studies 7, 8 and a 13-fold increased risk of neonatal seizure in a retrospective cohort study 9 after controlling for the neonatal infection. More worrisome, maternal fever in labor has been associated with a nine-fold increased risk of cerebral palsy in normal birth weight term infants, albeit with the independent effects of fever and infection not entirely distinguishable. 10 This study is, to our knowledge, the first trial of an intervention to prevent epidural fever. In this study, which was adequately powered to detect differences in maternal temperatures over time, acetaminophen was ineffective in preventing the gradual hyperthermia that has been observed with epidural analgesia. 11 The observation of acetaminophen's failure to impact epidural fever provides insights into possible mechanisms. Acetaminophen acts at the hypothalamic thermoregulatory set point; lack of effect suggest that epidural fever is not modulated through direct effects of either local anesthetic or intrathecal narcotics at this site. Several alternative mechanisms for epidural fever are still plausible. First, epidural analgesia could result in increased heat production through the shivering that is commonly observed in laboring women with epidural analgesia. Second, epidural analgesia, through an unknown mechanism, could trigger a maternal inflammatory response that is not responsive to acetaminophen, a weak anti-inflammatory agent.
Analysis of maternal and fetal serum samples collected during our trial demonstrate that epidural fever is associated with elevations in maternal and fetal serum IL-6, supporting an inflammatory basis for epidural fever. 12 De Jongh et al. 13 have also reported a relationship between epidural analgesia and increased maternal levels of IL-6. The mechanism through which epidural analgesia may trigger cytokine production during labor is not clear. However, the placenta is a rich source of cytokine production, 14 which may explain the unique response to epidural analgesia observed during labor. Increased placental inflammation has been reported in the setting of epidural fever, 15 supporting the placenta as a potential source. Our data suggest that placental inflammation is very common in the setting of epidural analgesia. Negative surveillance blood cultures in all cases of maternal fever emphasize that the epidural-associated inflammation does not appear to be infectious in nature. If epidural fever were an inflammatory process, irrespective of not being infectious, acetaminophen would not be expected to be an effective prophylactic agent. Anti-inflammatory agents may be necessary to prevent not only epidural fever but also the associated maternal and fetal cytokine activation.
One limitation of our study is that the dose of acetaminophen used to treat fever at our institution may not result in adequate maternal serum levels. Although we did not analyze acetaminophen levels in maternal serum, we did administer the highest dose given at our institution to pregnant patients with fever. Rectal administration was chosen to eliminate the variable absorption associated with oral administration, the inevitable result not only of delayed gastric emptying and maternal emesis during labor 16 but also delayed gastric emptying when epidural analgesia contains fentanyl. 17 While rectal absorption of acetaminophen can also be variable, rectal absorption of acetaminophen in pregnancy may be improved secondary to increased pelvic blood flow. Although the effective serum doses for the treatment of pyrexia have been well studied, less is known about the use of acetaminophen prophylactically to prevent pyrexia. However, our results are consistent with one other prophylactic study in which acetaminophen suppositories were ineffective in preventing temperature elevation following ischemic stroke at low dose (500 mg) and at higher doses (1000 mg) resulted in an average temperature reduction of only 0.31C. 18 Our results suggest that acetaminophen, given rectally at the standard dose of 650 mg, is unlikely to prevent the maternal hyperthermia associated with epidural analgesia.
An additional limitation of our study is our inability to exclude conclusively underlying or acquired infection as an etiology of epidural fever. Although we believe that the placental inflammation associated with epidural fever is noninfectious, increased inflammatory cytokines and placental inflammation due to infection cannot be excluded categorically. We did not obtain placental cultures or amniotic fluid cultures in patients with an intrauterine pressure catheter (IUPC). We plan to add further surveillance for infection in future studies. In the absence of a definitive test to differentiate between infectious and noninfectious fever, fever suppression will always carry a small risk of preventing timely detection of infection. Finally, the small number of patients in our study led to randomization not eliminating some differences between women in the two study arms. Women randomized to acetaminophen thus were, on average, 3.5 years older and 6.3 days more advanced in gestation. These factors may theoretically have increased the risk of fever in the women treated with acetaminophen, although controlling for these underlying differences using multiple logistic regression modeling did not change acetaminophen's lack of efficacy.
Maternal fever secondary to epidural analgesia carries important clinical and public health implications. In the absence of effective diagnostic tests that distinguish between noninfectious and infectious maternal fever, epidural fever leads to both maternal and neonatal antibiotic treatment as well as neonatal sepsis evaluations, unnecessarily increasing health-care expenditures. Understanding the mechanism of epidural fever will allow development of targeted prevention strategies such as prophylactic anti-inflammatory agents. Not only would prevention of epiduralinduced fever reduce health-care costs, but also avoiding intrauterine exposure to hyperthermia may prove to be neuroprotective for the fetus.
